Enter your email address
Submit
Write your message
Volume 19, Issue 2 (Iranian Journal of Breast Diseases 2026)
ijbd 2026, 19(2): 134-149 |
Back to browse issues page
Ethics code: IR.AJUMS.HGOLESTAN.REC.1404.038
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sasani M, Oraki A, Nazeri Z, Sasani N, Farzaneh M. Investigating the effect of supernatant from embryonic chicken liver hepatocyte cells on the secretion of the inflammatory factor IL-6, the anti-Inflammatory factor IL-10, and the expression of CyclinD1 and P53 genes in MCF-7 breast cancer cell line. ijbd 2026; 19 (2) :134-149
URL: http://ijbd.ir/article-1-1205-en.html
URL: http://ijbd.ir/article-1-1205-en.html
1- Department of Emergency Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Department of Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4- Department of Basic Sciences, Faculty of Veterinary Medicine, Chamran University of Ahvaz, Ahvaz, Iran
5- Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Clinical Research Development Unit, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran ,Maryamfarzaneh1394@gmail.com
2- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Department of Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4- Department of Basic Sciences, Faculty of Veterinary Medicine, Chamran University of Ahvaz, Ahvaz, Iran
5- Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Clinical Research Development Unit, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran ,
Abstract: (468 Views)
Introduction: The tumor microenvironment and factors secreted by adjacent cells play a crucial role in the progression or inhibition of cancer. This study was designed to investigate the effect of supernatant from chick embryo hepatocytes on the protein levels of inflammatory (IL-6) and anti-inflammatory (IL-10) factors as well as the expression of cell cycle-related genes in a breast cancer cell line (MCF-7).
Methods: In this in vitro experimental study, hepatocytes were isolated from chick embryo livers on the 10th day of incubation and cultured in DMEM/F12 medium containing 10% fetal bovine serum (FBS). After 48 hours, the supernatant was collected and filtered. MCF-7 cells were divided into two groups: control (treatment with basal medium) and intervention (treatment with supernatant) and incubated for 48 hours. IL-6 and IL-10 cytokine levels in the supernatant of MCF-7 cells were assessed using ELISA and relative expression of cyclinD1 and P53 genes was assessed using Real-Time PCR. Data analysis was performed using SPSS version 26 software and independent t-test, and a significance level of 0.05 was considered.
Results: Treatment of MCF-7 cells with hepatocyte supernatant significantly increased the protein levels of IL-10 (P=0.015) and IL-6 (P=0.013) in MCF-7 cells. Also, in these cells, P53 expression increased (P=0.002) and Cyclin D1 expression decreased (P=0.045) significantly.
Conclusion: Hepatocyte cell supernatant can exert regulatory and potential antitumor effects on MCF-7 cell line by inducing IL-10 expression, activating P53-dependent pathway and inhibiting Cyclin D1 expression. However, the concomitant increase in inflammatory factor IL-6 requires further mechanistic studies.
Methods: In this in vitro experimental study, hepatocytes were isolated from chick embryo livers on the 10th day of incubation and cultured in DMEM/F12 medium containing 10% fetal bovine serum (FBS). After 48 hours, the supernatant was collected and filtered. MCF-7 cells were divided into two groups: control (treatment with basal medium) and intervention (treatment with supernatant) and incubated for 48 hours. IL-6 and IL-10 cytokine levels in the supernatant of MCF-7 cells were assessed using ELISA and relative expression of cyclinD1 and P53 genes was assessed using Real-Time PCR. Data analysis was performed using SPSS version 26 software and independent t-test, and a significance level of 0.05 was considered.
Results: Treatment of MCF-7 cells with hepatocyte supernatant significantly increased the protein levels of IL-10 (P=0.015) and IL-6 (P=0.013) in MCF-7 cells. Also, in these cells, P53 expression increased (P=0.002) and Cyclin D1 expression decreased (P=0.045) significantly.
Conclusion: Hepatocyte cell supernatant can exert regulatory and potential antitumor effects on MCF-7 cell line by inducing IL-10 expression, activating P53-dependent pathway and inhibiting Cyclin D1 expression. However, the concomitant increase in inflammatory factor IL-6 requires further mechanistic studies.
Keywords: Breast cancer, Supernatant, Hepatocyte cell, Liver, Chicken, Interleukin-6, Interleukin-10
Type of Study: Research |
Subject:
molecular cell
Received: 2025/09/15 | Accepted: 2026/06/13 | Published: 2026/07/26
Received: 2025/09/15 | Accepted: 2026/06/13 | Published: 2026/07/26
References
1. Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine. 2024;103(3):e36905. doi: 10.1097/MD.0000000000036905 [DOI:10.1097/MD.0000000000036905] [PMID] [PMCID]
2. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British journal of radiology. 2022;95(1130):20211033. doi: 10.1259/bjr.20211033 [DOI:10.1259/bjr.20211033] [PMID] [PMCID]
3. Li X, Zhang H, Yang H, Song Y, Zhang F, Wang A. Modifiable risk factors for breast cancer: insights from systematic reviews. Public Health Nursing. 2025;42(2):1060-71. doi:10.1111/phn.13504 [DOI:10.1111/phn.13504] [PMID]
4. García-Sancha N, Corchado-Cobos R, Pérez-Losada J. Understanding susceptibility to breast cancer: from risk factors to prevention strategies. International Journal of Molecular Sciences. 2025;26(7):2993. doi:10.3390/ijms26072993 [DOI:10.3390/ijms26072993] [PMID] [PMCID]
5. Dessie ZG, Zewotir T. Global determinants of breast cancer mortality: a comprehensive meta-analysis of clinical, demographic, and lifestyle risk factors. BMC Public Health. 2025;25(1):2640. doi: 10.1186/s12889-025-24036-w [DOI:10.1186/s12889-025-24036-w] [PMID] [PMCID]
6. Li T, Isautier J, Lee JM, Marinovich ML, Houssami N. Performance of Digital Breast Tomosynthesis Versus Digital Mammography in Women With a Family History of Breast Cancer: A Systematic Review. Clinical Breast Cancer. 2025;25(2):e103-e12. doi: 10.1016/j.clbc.2024.09.013 [DOI:10.1016/j.clbc.2024.09.013] [PMID] [PMCID]
7. Wang H, Guo Q, Shen Y, Ding K, Chen Y, Wang X, et al. ARTS Confers Chemoresistance of Breast Cancer by Inducing Apoptosis-Dependent Autophagy via Livin-MDM2-p53 Pathway. Research. 2026;9:1086. doi:10.34133/research. 1086 [DOI:10.34133/Research]
8. Anand V, El-Dana F, Baran N, Borgman J, Yin Z, Zhao H, et al. GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial function. Oncogene. 2025;44(30):2646-61. doi: 10.1038/s41388-025-03432-x [DOI:10.1038/s41388-025-03432-x] [PMID] [PMCID]
9. Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 biology into effective treatments. Nature Reviews Rheumatology. 2020;16(6):335-45. doi:10.1038/s41584-020-0419-z [DOI:10.1038/s41584-020-0419-z] [PMID] [PMCID]
10. El-Shemi AG, Alqurashi A, Abdulrahman JA, Alzahrani HD, Almwalad KS, Felfilan HH, et al. IL-10-Directed cancer immunotherapy: Preclinical advances, clinical insights, and future perspectives. Cancers. 2025;17(6):1012. doi:10.3390/cancers17061012 [DOI:10.3390/cancers17061012] [PMID] [PMCID]
11. Rubin SM, Sage J, Skotheim JM. Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy. Cancer Research. 2026. doi:10.1158/0008-5472.CAN-25-0916 [DOI:10.1158/0008-5472.CAN-25-0916] [PMID] [PMCID]
12. Miura Y, Sakai Y, Nishikawa M, Leclerc E. A computational model of inflammation reveals crosstalk among energy metabolism, oxidative stress, insulin, and cytokines in hepatocytes during early MASLD progression. Toxicological Sciences. 2026;209(2):kfaf176. doi:10.1093/toxsci/kfaf176 [DOI:10.1093/toxsci/kfaf176] [PMID]
13. Ge W, Wang Z, Chen Y, Tang X, Lou Z, Chen J, et al. Hepatocyte-like cell therapy for end-stage liver disease: From basic science to clinical application. Liver Research. 2026. doi:10.1016/j.livers.2026.01.005 [DOI:10.1016/j.livres.2026.01.005] [PMID] [PMCID]
14. Kostallari E, Schwabe RF, Guillot A. Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells. Cellular & Molecular Immunology. 2025;22(10):1205-25. doi:10.1038/s41423-025-01313-7 [DOI:10.1038/s41423-025-01313-7] [PMID] [PMCID]
15. Obenauf AC, Massagué J. Surviving at a Distance: Organ-Specific Metastasis. Trends Cancer. 2015;1(1):76-91. doi:10.1016/j.trecan.2015.07.009 [DOI:10.1016/j.trecan.2015.07.009] [PMID] [PMCID]
16. Liu C, Mohan SC, Wei J, Seki E, Liu M, Basho R, et al. Breast cancer liver metastasis: Pathogenesis and clinical implications. Frontiers in Oncology. 2022;12:1043771. doi:10.3389/fonc.2022.1043771 [DOI:10.3389/fonc.2022.1043771] [PMID] [PMCID]
17. Taylor DP. Breast cancer metastatic dormancy and emergence in the hepatic niche: University of Pittsburgh, 2013.
18. Wang C, Fan P, Zhou Y, Ma M, Zhong H, Liu L, et al. Heterogeneous tissue-specific macrophages orchestrate metastatic organotropism of breast cancer: implications for promising therapeutics. Journal of Translational Medicine. 2025;23(1):692. doi:10.1186/s12967-025-06660-7 [DOI:10.1186/s12967-025-06660-7] [PMID] [PMCID]
19. Shooshtari MK, Vastegani SM, Farbood Y, Sarkaki A, Bayati V, Nejaddehbashi F, et al. Neuroprotective Potential of Conditioned Medium from Adipose and Liver Mesenchymal Stem Cells in a Rat Model of Global Cerebral Ischemia-Reperfusion Injury. Current Molecular Medicine. 2025. doi:10.2174/0115665240351634250506164609 [DOI:10.2174/0115665240351634250506164609] [PMID]
20. Mahdavi R, Jonoush ZA, Ghafourian M, Khoshnam SE, Dehbashi FN, Farzaneh M. The Effect of Remdesivir as an anti-COVID-19 Drug on Chicken Hepatocyte Enzymes; an in vitro Study. Iranian Journal of Medical Microbiology. 2023;17(3):309. doi:10.30699/ijmm.17.3.309 [DOI:10.30699/ijmm.17.3.309]
21. Abdollahi MR, Kianersi F, Moosavi SS, Dastan D, Asadi S. Identification and expression analysis of two genes involved in the biosynthesis of t-anethole in fennel (Foeniculum vulgare Mill.) and their up-regulation in leaves in response to methyl jasmonate treatments. Journal of Plant Growth Regulation. 2023;42(2):759-70. doi:10.1007/s00344-022-10583-8 [DOI:10.1007/s00344-022-10583-8]
22. Ibragimova MK, Tsyganov MM, Kravtsova EA, Tsydenova IA, Litviakov NV. Organ-specificity of breast cancer metastasis. International journal of molecular sciences. 2023;24(21):15625. doi:10.3390/ijms242115625 [DOI:10.3390/ijms242115625] [PMID] [PMCID]
23. He M, Hu Y, Wang D, Sun M, Li H, Yan P, et al. Value of CT-based radiomics in predicting the efficacy of anti-HER2 therapy for patients with liver metastases from breast cancer. Frontiers in Oncology. 2022;12:852809. doi:10.3389/fonc.2022.852809 [DOI:10.3389/fonc.2022.852809] [PMID] [PMCID]
24. Bullock E, Brunton VG. E-cadherin-mediated cell-cell adhesion and invasive lobular breast cancer. A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy. 2025:259-75. doi:10.1007/978-3-031-70875-6_14 [DOI:10.1007/978-3-031-70875-6_14] [PMID]
25. Zhang W, Wang J, Li H, Zhang X, Yao D, Zhang H, et al. TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherin. iScience. 2025;28(3). doi:10.1016/j.isci.2025.111989 [DOI:10.1016/j.isci.2025.111989] [PMID] [PMCID]
26. Ge C, Huang X, Zhang S, Yuan M, Tan Z, Xu C, et al. In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. Cancer Cell International. 2023;23(1):14. doi:10.1186/s12935-023-02853-6 [DOI:10.1186/s12935-023-02853-6] [PMID] [PMCID]
27. Rada M, Tsamchoe M, Kapelanski-Lamoureux A, Hassan N, Bloom J, Petrillo S, et al. Cancer cells promote phenotypic alterations in hepatocytes at the edge of cancer cell nests to facilitate vessel Co-option establishment in colorectal cancer liver metastases. Cancers. 2022;14(5):1318. doi:10.3390/cancers14051318 [DOI:10.3390/cancers14051318] [PMID] [PMCID]
28. Mirabdollahi M, Javanmard SH, Sadeghi-Aliabadi H. In vitro assessment of cytokine expression profile of MCF-7 cells in response to hWJ-MSCs secretome. Advanced Pharmaceutical Bulletin. 2019;9(4):649. doi:10.15171/apb. 2019.075 [DOI:10.15171/apb.2019.075] [PMID] [PMCID]
29. Noori S, Hassan ZM. Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis. Free Radical Biology and Medicine. 2012;52(9):1987-99. doi:10.1016/j.freeradbiomed.2012.01.026 [DOI:10.1016/j.freeradbiomed.2012.01.026] [PMID]
30. Khamooshi R, Salimi A, Halabian R, Saeedi P. Apoptotic effects of mesenchymal stem cells' conditioned medium on colorectal cancer cell lines. Tissue and Cell. 2023;85:102247. doi:10.1016/j.tice.2023.102247 [DOI:10.1016/j.tice.2023.102247] [PMID]
31. Pashaei-Asl R, Pashaiasl M, Ebrahimie E, Ataei ML, Paknejad M. Apoptotic effects of human amniotic fluid mesenchymal stem cells conditioned medium on human MCF-7 breast cancer cell line. BioImpacts: BI. 2022;13(3):191. doi:10.34172/bi. 2022.23813 [DOI:10.34172/bi.2022.23813] [PMID] [PMCID]
32. Kostolomova E, Lozovaya P, Polyanskih E, Timokhina TK, Paromova YI. Studying the anti-inflammatory activity of Bifidobacterium bifidum supernatants and chicken embryo cells on a model of opisthochic invasion. Russian Journal of Immunology. 2024;27(2):181 6. [DOI:10.46235/1028-7221-16675-STA]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
